SCHEMBL28410288

SCHEMBL28410288

COc1ccc(CN2C(=O)CCc3c(OC[C@]4(O)CCN(C(=O)OC(C)(C)C)C[C@H]4O[Si](C)(C)C(C)(C)C)cc(F)c(F)c32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.34
▸ USP7 Q93009 1/20 0.33
▸ P2RX3 P56373 2/20 0.33
▸ HTR6 P50406 1/20 0.32
▸ BACE1 P56817 2/20 0.32
▸ P2RX7 Q99572 1/20 0.32
▸ GALR2 O43603 1/20 0.32
▸ GALR1 P47211 1/20 0.32
▸ GPR119 Q8TDV5 1/20 0.32
▸ PDE4A P27815 1/20 0.31
▸ PDE4B Q07343 1/20 0.31
▸ PDE4C Q08493 1/20 0.31
▸ PDE4D Q08499 1/20 0.31
▸ CTSD P07339 1/20 0.31
▸ CTSE P14091 1/20 0.31
▸ ROCK2 O75116 1/20 0.31
▸ DNMT3A Q9Y6K1 1/20 0.31
▸ TLR9 Q9NR96 1/20 0.31
▸ GRM2 Q14416 2/20 0.31
▸ ALK Q9UM73 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28413584 0.94 P2RX7 (0.33) KDM1AUSP7P2RX3HTR6BACE1
SCHEMBL17543038 0.93 GRM2 (0.31) GRM2
SCHEMBL28891831 0.92 HTR6 (0.34) KDM1AUSP7P2RX3HTR6BACE1
SCHEMBL28413757 0.92 HTR6 (0.34) KDM1AUSP7P2RX3HTR6BACE1
SCHEMBL28413288 0.89 HTR6 (0.35) KDM1AP2RX3HTR6BACE1PDE4A
SCHEMBL28418880 0.89 HTR6 (0.35) KDM1AP2RX3HTR6BACE1PDE4A
SCHEMBL28416421 0.89 KDM1A (0.35) KDM1AUSP7P2RX3HTR6BACE1
SCHEMBL17543545 0.88 OPRD1 (0.31) GRM2
SCHEMBL17543543 0.88 OPRD1 (0.31) GRM2
SCHEMBL17543459 0.85 GRIN2C (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106795117-B Heterobicyclic compounds and their use for the treatment of tuberculosis 大塚制药株式会社 2020-06-26 — — CN disclosed
Send feedback